» Articles » PMID: 22121384

The Asthma-COPD Overlap Syndrome: A Common Clinical Problem in the Elderly

Overview
Date 2011 Nov 29
PMID 22121384
Citations 87
Authors
Affiliations
Soon will be listed here.
Abstract

Many patients with breathlessness and chronic obstructive lung disease are diagnosed with either asthma, COPD, or-frequently-mixed disease. More commonly, patients with uncharacterized breathlessness are treated with therapies that target asthma and COPD rather than one of these diseases. This common practice represents the difficulty in distinguishing these disorders clinically, particularly in patients with a history that does not easily differentiate asthma from COPD. A common clinical scenario is an older former smoker with partially reversible or fixed airflow obstruction and evidence of atopy, demonstrating "overlap" features of asthma and COPD. We stress that asthma-COPD overlap syndrome becomes more prevalent with advancing age as patients respond less favorably to guideline-recommended drug therapy. We review the similarities and differences in clinical characteristics between these disorders, and their physiologic and inflammatory profiles within the context of the aging patient. We underscore the difficulties in differentiating asthma from COPD in current or former smokers, share our institutional experience with overlap syndrome, and highlight the need for new research to better characterize and investigate this important clinical phenotype.

Citing Articles

Influence and distinctions of particulate matter exposure across varying etiotypes in chronic obstructive pulmonary disease (COPD) mouse model.

Hur J, Rhee C, Yoon H, Park C, Lim J, An T J Inflamm (Lond). 2024; 21(1):42.

PMID: 39487493 PMC: 11529024. DOI: 10.1186/s12950-024-00416-8.


Assessment of functional diversities in patients with Asthma, COPD, Asthma-COPD overlap, and Cystic Fibrosis (CF).

Kraemer R, Baty F, Smith H, Minder S, Gallati S, Brutsche M PLoS One. 2024; 19(2):e0292270.

PMID: 38377145 PMC: 10878531. DOI: 10.1371/journal.pone.0292270.


Serum MMP3 and IL1-RA levels may be useful biomarkers for detecting asthma and chronic obstructive pulmonary disease overlap in patients with asthma.

Takada K, Suzukawa M, Tashimo H, Ohshima N, Fukutomi Y, Kobayashi N World Allergy Organ J. 2023; 16(11):100840.

PMID: 38020287 PMC: 10663683. DOI: 10.1016/j.waojou.2023.100840.


Medication adherence in Medicare-enrolled older adults with asthma and chronic obstructive pulmonary disease before and during COVID-19 pandemic.

Liu L, Silva Almodovar A, Nahata M Ther Adv Chronic Dis. 2023; 14:20406223231205796.

PMID: 37822769 PMC: 10563468. DOI: 10.1177/20406223231205796.


β2-Adrenoceptor Agonists in Asthma or Chronic Obstructive Pulmonary Disease and Risk of Parkinson's Disease: Nested Case-Control Study.

Paakinaho A, Tiihonen M, Koskela H, Koponen M, Tiihonen J, Hartikainen S Clin Epidemiol. 2023; 15:695-705.

PMID: 37332323 PMC: 10274847. DOI: 10.2147/CLEP.S405325.


References
1.
Chalmers G, MacLeod K, Thomson L, Little S, McSharry C, Thomson N . Smoking and airway inflammation in patients with mild asthma. Chest. 2001; 120(6):1917-22. DOI: 10.1378/chest.120.6.1917. View

2.
Bateman E, Hurd S, Barnes P, Bousquet J, Drazen J, Fitzgerald J . Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008; 31(1):143-78. DOI: 10.1183/09031936.00138707. View

3.
Walker S, Monteil M, Phelan K, Lasserson T, Walters E . Anti-IgE for chronic asthma in adults and children. Cochrane Database Syst Rev. 2006; (2):CD003559. DOI: 10.1002/14651858.CD003559.pub3. View

4.
Brutsche M, Downs S, Schindler C, Gerbase M, Schwartz J, Frey M . Bronchial hyperresponsiveness and the development of asthma and COPD in asymptomatic individuals: SAPALDIA cohort study. Thorax. 2006; 61(8):671-7. PMC: 2104688. DOI: 10.1136/thx.2005.052241. View

5.
Martin R, Szefler S, King T, Kraft M, Boushey H, Chinchilli V . The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial. J Allergy Clin Immunol. 2007; 119(1):73-80. PMC: 2872157. DOI: 10.1016/j.jaci.2006.10.035. View